Overview of scientific publications (2019-2023) on Gastrointestinal Inflammation associated with Orlistat: An integrative review of the literature
Autor(a) principal: | |
---|---|
Data de Publicação: | 2024 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/44969 |
Resumo: | Objective: To conduct an integrative literature review to assess the role of Orlistat in inducing gastrointestinal inflammation, identify the underlying mechanisms, and provide a comprehensive overview of existing studies on the subject from 2019 to 2023. Method: Follows an integrative review approach, aiming to aggregate the results of published research and present them from a research question. Searches were conducted in various databases, including MEDLINE (via the PubMed portal of the National Library of Medicine), LILACS (Latin American and Caribbean Literature in Health Sciences), EMBASE, SCOPUS, and Web of Science. Results: 11 publications were selected for inclusion in the study. This relatively small number of included studies, compared to the initial number (195) of identified publications, reflects the rigor of the selection criteria and the emphasis on the quality and relevance of the data. Regarding the categories, Inflammation Biomarkers, Involved Mediators, Effects at Different Doses, and Impact of Treatment Duration were identified. Conclusion: It is concluded that the personalization of treatment, considering individual characteristics and patient response, is essential to maximize benefits and minimize adverse effects. |
id |
UNIFEI_9a008260426dbafe2a16e06382423cde |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/44969 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Overview of scientific publications (2019-2023) on Gastrointestinal Inflammation associated with Orlistat: An integrative review of the literaturePanorama de las publicaciones científicas (2019-2023) sobre Inflamación Gastrointestinal asociada a Orlistat: Una revisión integradora de la literaturaPanorama das publicações científicas (2019-2023) sobre Inflamação Gastrointestinal associada à Orlistate: Uma revisão integrativa da literaturaOrlistatGastroenterologyGastrointestinal inflammationIntegrative reviewAdverse effects.OrlistateGastroenterologiaInflamação gastrointestinalRevisão integrativaEfeitos adversos.OrlistatGastroenterologíaInflamación gastrointestinalRevisión integrativaEfectos adversos.Objective: To conduct an integrative literature review to assess the role of Orlistat in inducing gastrointestinal inflammation, identify the underlying mechanisms, and provide a comprehensive overview of existing studies on the subject from 2019 to 2023. Method: Follows an integrative review approach, aiming to aggregate the results of published research and present them from a research question. Searches were conducted in various databases, including MEDLINE (via the PubMed portal of the National Library of Medicine), LILACS (Latin American and Caribbean Literature in Health Sciences), EMBASE, SCOPUS, and Web of Science. Results: 11 publications were selected for inclusion in the study. This relatively small number of included studies, compared to the initial number (195) of identified publications, reflects the rigor of the selection criteria and the emphasis on the quality and relevance of the data. Regarding the categories, Inflammation Biomarkers, Involved Mediators, Effects at Different Doses, and Impact of Treatment Duration were identified. Conclusion: It is concluded that the personalization of treatment, considering individual characteristics and patient response, is essential to maximize benefits and minimize adverse effects.Objetivo: Realizar una revisión integrativa de la literatura para evaluar el papel del Orlistat en la inducción de inflamación gastrointestinal, identificar los mecanismos subyacentes y proporcionar una visión integral de los estudios existentes sobre el tema en el período de 2019 a 2023. Metodología: Sigue un enfoque de revisión integrativa, con el propósito de agregar los resultados de investigaciones publicadas y presentarlos a partir de una pregunta de investigación. Se realizaron búsquedas en varias bases de datos, incluyendo MEDLINE (a través del portal PubMed de la Biblioteca Nacional de Medicina), LILACS (Literatura Latinoamericana y del Caribe en Ciencias de la Salud), EMBASE, SCOPUS y Web of Science. Resultados: Se seleccionaron 11 publicaciones para inclusión en el estudio. Este número relativamente pequeño de estudios incluidos, en comparación con el número inicial (195) de publicaciones identificadas, refleja la rigurosidad de los criterios de selección y el énfasis en la calidad y relevancia de los datos. En cuanto a las categorías, se identificaron Biomarcadores de Inflamación, Mediadores Involucrados, Efectos en Diferentes Dosis e Impacto de la Duración del Tratamiento. Conclusión: Se concluye que la personalización del tratamiento, considerando las características individuales y la respuesta del paciente, es fundamental para maximizar los beneficios y minimizar los efectos adversos.Objetivo: Realizar uma revisão integrativa da literatura para avaliar o papel do Orlistate na indução de inflamação gastrointestinal, identificar os mecanismos subjacentes e fornecer uma visão abrangente dos estudos existentes sobre o assunto no período de 2019 a 2023. Metodologia: Segue uma abordagem de revisão integrativa, com o propósito de agregar os resultados de pesquisas publicadas e apresentá-los a partir de uma questão de pesquisa. Foram realizadas buscas em diversas bases de dados, incluindo o MEDLINE (via portal PubMed da National Library of Medicine), LILACS (Literatura Latino-americana e do Caribe em Ciências da Saúde), EMBASE, SCOPUS e Web of Science. Resultados: 11 publicações foram selecionadas para inclusão no estudo. Este número relativamente pequeno de estudos incluídos, em comparação ao número inicial (195) de publicações identificadas, reflete a rigidez dos critérios de seleção e a ênfase na qualidade e pertinência dos dados. Quanto as categorias, identificou-se Biomarcadores de Inflamação, Mediadores Envolvidos, Efeitos em Diferentes Doses e Impacto da Duração do Tratamento. Conclusão: Conclui-se que a personalização do tratamento, considerando as características individuais e a resposta do paciente, é fundamental para maximizar os benefícios e minimizar os efeitos adversos.Research, Society and Development2024-02-14info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/4496910.33448/rsd-v13i2.44969Research, Society and Development; Vol. 13 No. 2; e5113244969Research, Society and Development; Vol. 13 Núm. 2; e5113244969Research, Society and Development; v. 13 n. 2; e51132449692525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/44969/35932Copyright (c) 2024 Kamila Luana Santos Silva; Carolina Barbosa Redig; Giovanna Eduarda Mauro Furtado; Glaucya Abdalla Scheffer; Eduarda Oliveira Ferreira; Isabela Guerreiro Diniz; Márcia Cristina Monteiro Guimarãeshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSilva, Kamila Luana Santos Redig, Carolina Barbosa Furtado, Giovanna Eduarda Mauro Scheffer, Glaucya Abdalla Ferreira, Eduarda Oliveira Diniz, Isabela Guerreiro Guimarães, Márcia Cristina Monteiro 2024-03-04T09:47:20Zoai:ojs.pkp.sfu.ca:article/44969Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-03-04T09:47:20Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Overview of scientific publications (2019-2023) on Gastrointestinal Inflammation associated with Orlistat: An integrative review of the literature Panorama de las publicaciones científicas (2019-2023) sobre Inflamación Gastrointestinal asociada a Orlistat: Una revisión integradora de la literatura Panorama das publicações científicas (2019-2023) sobre Inflamação Gastrointestinal associada à Orlistate: Uma revisão integrativa da literatura |
title |
Overview of scientific publications (2019-2023) on Gastrointestinal Inflammation associated with Orlistat: An integrative review of the literature |
spellingShingle |
Overview of scientific publications (2019-2023) on Gastrointestinal Inflammation associated with Orlistat: An integrative review of the literature Silva, Kamila Luana Santos Orlistat Gastroenterology Gastrointestinal inflammation Integrative review Adverse effects. Orlistate Gastroenterologia Inflamação gastrointestinal Revisão integrativa Efeitos adversos. Orlistat Gastroenterología Inflamación gastrointestinal Revisión integrativa Efectos adversos. |
title_short |
Overview of scientific publications (2019-2023) on Gastrointestinal Inflammation associated with Orlistat: An integrative review of the literature |
title_full |
Overview of scientific publications (2019-2023) on Gastrointestinal Inflammation associated with Orlistat: An integrative review of the literature |
title_fullStr |
Overview of scientific publications (2019-2023) on Gastrointestinal Inflammation associated with Orlistat: An integrative review of the literature |
title_full_unstemmed |
Overview of scientific publications (2019-2023) on Gastrointestinal Inflammation associated with Orlistat: An integrative review of the literature |
title_sort |
Overview of scientific publications (2019-2023) on Gastrointestinal Inflammation associated with Orlistat: An integrative review of the literature |
author |
Silva, Kamila Luana Santos |
author_facet |
Silva, Kamila Luana Santos Redig, Carolina Barbosa Furtado, Giovanna Eduarda Mauro Scheffer, Glaucya Abdalla Ferreira, Eduarda Oliveira Diniz, Isabela Guerreiro Guimarães, Márcia Cristina Monteiro |
author_role |
author |
author2 |
Redig, Carolina Barbosa Furtado, Giovanna Eduarda Mauro Scheffer, Glaucya Abdalla Ferreira, Eduarda Oliveira Diniz, Isabela Guerreiro Guimarães, Márcia Cristina Monteiro |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Silva, Kamila Luana Santos Redig, Carolina Barbosa Furtado, Giovanna Eduarda Mauro Scheffer, Glaucya Abdalla Ferreira, Eduarda Oliveira Diniz, Isabela Guerreiro Guimarães, Márcia Cristina Monteiro |
dc.subject.por.fl_str_mv |
Orlistat Gastroenterology Gastrointestinal inflammation Integrative review Adverse effects. Orlistate Gastroenterologia Inflamação gastrointestinal Revisão integrativa Efeitos adversos. Orlistat Gastroenterología Inflamación gastrointestinal Revisión integrativa Efectos adversos. |
topic |
Orlistat Gastroenterology Gastrointestinal inflammation Integrative review Adverse effects. Orlistate Gastroenterologia Inflamação gastrointestinal Revisão integrativa Efeitos adversos. Orlistat Gastroenterología Inflamación gastrointestinal Revisión integrativa Efectos adversos. |
description |
Objective: To conduct an integrative literature review to assess the role of Orlistat in inducing gastrointestinal inflammation, identify the underlying mechanisms, and provide a comprehensive overview of existing studies on the subject from 2019 to 2023. Method: Follows an integrative review approach, aiming to aggregate the results of published research and present them from a research question. Searches were conducted in various databases, including MEDLINE (via the PubMed portal of the National Library of Medicine), LILACS (Latin American and Caribbean Literature in Health Sciences), EMBASE, SCOPUS, and Web of Science. Results: 11 publications were selected for inclusion in the study. This relatively small number of included studies, compared to the initial number (195) of identified publications, reflects the rigor of the selection criteria and the emphasis on the quality and relevance of the data. Regarding the categories, Inflammation Biomarkers, Involved Mediators, Effects at Different Doses, and Impact of Treatment Duration were identified. Conclusion: It is concluded that the personalization of treatment, considering individual characteristics and patient response, is essential to maximize benefits and minimize adverse effects. |
publishDate |
2024 |
dc.date.none.fl_str_mv |
2024-02-14 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/44969 10.33448/rsd-v13i2.44969 |
url |
https://rsdjournal.org/index.php/rsd/article/view/44969 |
identifier_str_mv |
10.33448/rsd-v13i2.44969 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/44969/35932 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 13 No. 2; e5113244969 Research, Society and Development; Vol. 13 Núm. 2; e5113244969 Research, Society and Development; v. 13 n. 2; e5113244969 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052637580886016 |